Search Results from Other Databases

 
Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study
Autologous Stem Cell Transplantation for Crohn's Disease
Optimizing Cimzia in Crohn's Patients
Infliximab, Regulatory T Cells, IL2 and Crohn's Disease
Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Devel
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Corticosteroid Dosage for Crohn's Disease Flare
Imaging Biomarkers in Crohn's Associated Spondyloarthritis
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Tre
A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Com
A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease
Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease
Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease
FMT in Pediatric Crohn's Disease
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Autologous Stem Cell Transplant for Crohn's Disease
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon i
Fecal Microbial Transplantation in Patients With Crohn's Disease
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Resp
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Respo
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Pediatric MSC-AFP Sub-study for Crohn's Fistula
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Efficacy and Safety of TD-1473 in Crohn's Disease
52-Week Crohn's Disease Study
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease